Tout DSpace

Parcourir par sujet "hypofractionated radiotherapy"

Voici les éléments 1-6 de 6

    • An exploratory study of radiation dermatitis in breast cancer patients 

      Alexopoulou E., Katsila T., Tolia M., Tsoukalas N., Leontsinidis M., Kyrgias G., Kouloulias V., Patrinos G.P., Spyropoulou D., Kardamakis D. (2018)
      Background/Aim: Radiation dermatitis is observed in 95% of breast cancer patients receiving radiotherapy. The aim of this study was to explore the correlation between protein expression in tumor cells and the risk of ...

    • Is locally advanced head-neck cancer one more candidate for accelerated hypofractionation? 

      KOUKOURAKIS I.M., ZYGOGIANNI A., KOULOULIAS V., KYRGIAS G., PANTELIADOU M., NANOS C., ABATZOGLOU I., KOUKOURAKIS M.I. (2021)
      Background/Aim: Hypofractionated accelerated radiotherapy (HypoAR) is widely applied for the treatment of early laryngeal cancer. Its role in locally advanced head-neck cancer (LA-HNC) is unexplored. Patients and Methods: ...

    • Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer 

      Alexidis P., Karatzoglou S., Dragoumis D., Drevelegas K., Tzitzikas I., Hatzimouratidis K., Chrisogonidis I., Ioannidis A., Katsios I.N., Zarogoulidis P., Sapalidis K., Koulouris C., Michalopoulos N., Giannakidis D., Aidoni Z., Fyntanidou V., Amaniti A., Boniou K., Kesisoglou I., Vagionas A., Romanidis K., Oikonomou P., Goganau A.M., Petanidis S., Maragouli E., Kosmidis C. (2020)
      Background: Prostate cancer is considered to be highly sensitive to changes in radiation therapy dose per fraction, specifically to hypofractionation. An increase in the fractionation dose could cause a higher increase to ...

    • Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 

      Mazzola R., Jereczek-Fossa B.A., Franceschini D., Tubin S., Filippi A.R., Tolia M., Lancia A., Minniti G., Corradini S., Arcangeli S., Scorsetti M., Alongi F. (2020)
      Background: During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed ...

    • A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer 

      Kouloulias V., Mosa E., Zygogianni A., Kypraiou E., Georgakopoulos J., Platoni K., Antypas C., Kyrgias G., Tolia M., Papadimitriou C., Psyrri A., Patatoukas G., Dilvoi M., Armpilia C., Theodorou K., Kalogeridi M.-A., Beli I., Kouvaris J., Kelekis N. (2016)
      Introduction: The aim of this analysis was a retrospective evaluation of the efficacy and toxicity of 2 hypofractionated irradiation schedules compared to conventional therapy in post-mastectomy patients. Methods: 3 ...

    • The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: Early results of a randomized trial 

      Alexidis P., Dragoumis D., Karatzoglou S., Drevelegas K., Tzitzikas I., Hatzimouratidis K., Chrisogonidis I., Giannakidis D., Koulouris C., Katsaounis A., Michalopoulos N., Huang H., Li Q., Aidoini Z., Fyntanidou V., Amaniti A., Hohenforst-Schmidt W., Maragouli E., Petanidis S., Zarogoulidis P., Sapalidis K., Kosmidis C., Romanidis K., Oinkonomou P., Vagionas A., Nikolaos-Katsios I., Ioannidis A., Boniou K., Kesisoglou I. (2019)
      Background: Prostate cancer is considered to have a special biology which could affect the radiation therapy result based on the selected fractionation scheme. We present the preliminary results of a randomized trial ...